What is the recommended dosage and usage of hyoscyamine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hyoscyamine Dosage and Usage

The maximum daily dose of hyoscyamine is 1.5 mg for adults, administered as 0.125 mg orally/sublingually every 4 hours as needed, with dosing adjusted based on patient age, weight, and clinical indication. 1, 2

Standard Adult Dosing

For adults and pediatric patients ≥12 years:

  • Oral drops: 1-2 mL every 4 hours as needed (maximum 12 mL/24 hours) 2
  • Elixir: 1-2 teaspoonfuls every 4 hours as needed (maximum 12 teaspoonfuls/24 hours) 2
  • Tablets/sublingual: 0.125 mg every 4 hours as needed (maximum 1.5 mg/24 hours) 1

Pediatric Dosing

For children 2 to <12 years:

  • Weight-based dosing is essential, with maximum daily limits strictly observed 2
  • Oral drops: 0.25-1 mL every 4 hours (maximum 6 mL/24 hours) 2
  • Elixir dosing by weight:
    • 10 kg (22 lb): 1.25 mL (1/4 teaspoon)
    • 20 kg (44 lb): 2.5 mL (1/2 teaspoon)
    • 40 kg (88 lb): 3.75 mL (3/4 teaspoon)
    • 50 kg (110 lb): 5 mL (1 teaspoon)
    • Maximum 6 teaspoonfuls/24 hours 2

For infants <2 years:

  • Dosing is strictly weight-based using oral drops 2
  • 3.4 kg (7.5 lb): 4 drops every 4 hours (maximum 24 drops/24 hours)
  • 5 kg (11 lb): 5 drops every 4 hours (maximum 30 drops/24 hours)
  • 7 kg (15 lb): 6 drops every 4 hours (maximum 36 drops/24 hours)
  • 10 kg (22 lb): 8 drops every 4 hours (maximum 48 drops/24 hours) 2

Clinical Applications

Palliative Care - Excessive Secretions:

  • Hyoscyamine 0.125 mg PO/ODT/SL every 4 hours as needed is a second-line option when glycopyrrolate is insufficient 1
  • Alternative routes (rectal, transdermal, subcutaneous, IV) may be used when oral administration is not feasible 1

Malignant Bowel Obstruction:

  • Used as an anticholinergic agent when other measures fail, alongside scopolamine and glycopyrrolate 1
  • Administered via alternative routes when oral intake is compromised 1

Chronic Abdominal Pain:

  • Can be used as an antispasmodic in hypermobile Ehlers-Danlos syndrome and related conditions 1

Safety Monitoring and Contraindications

Monitor for anticholinergic side effects:

  • Dry mouth, urinary retention, constipation, and blurred vision are common 1
  • In elderly or post-stroke patients, hyoscyamine may cause more CNS effects compared to glycopyrrolate, which does not cross the blood-brain barrier 1

Use with extreme caution or avoid in:

  • Cardiac patients with tachycardia, angina, or cardiac failure 3
  • Prostatic hypertrophy with urinary retention 3
  • Glaucoma patients should be counseled to seek emergency care if experiencing eye pain, redness, decreased vision, nausea, vomiting, or headache after administration 3

Clinical Considerations

Gastroesophageal reflux disease:

  • Hyoscyamine and related anticholinergics increase esophageal acid reflux episodes and are not recommended for GERD treatment 4

Endoscopic procedures:

  • Evidence does not support routine use during colonoscopy or gastroscopy 3
  • May be considered during ERCP, though glucagon remains standard 3, 5

Cost and administration:

  • Oral hyoscyamine is considerably less expensive than IV glucagon for antispasmodic effects 6
  • Sublingual administration provides rapid onset when needed 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.